-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
2',5-Difluoro-2'-deoxycytidine
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/581772-30-7.gif)
| Category | Hepatitis C Virus (HCV) |
| CAS | 581772-30-7 |
| Description | 2',5-Difluoro-2'-deoxycytidine has potent activity against HCV and toxicity to ribosomal RNA (rRNA). |
Product Information
| Synonyms | 2'-deoxy-2',5-difluorocytidine; Cytidine, 2'-deoxy-2',5-difluoro-; 4-amino-5-fluoro-1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one |
| IUPAC Name | 4-amino-5-fluoro-1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
| Molecular Weight | 263.20 |
| Molecular Formula | C9H11F2N3O4 |
| Canonical SMILES | C1=C(C(=NC(=O)N1C2C(C(C(O2)CO)O)F)N)F |
| InChI | InChI=1S/C9H11F2N3O4/c10-3-1-14(9(17)13-7(3)12)8-5(11)6(16)4(2-15)18-8/h1,4-6,8,15-16H,2H2,(H2,12,13,17)/t4-,5-,6-,8-/m1/s1 |
| InChIKey | OCMREAUZQAIMOT-UAKXSSHOSA-N |
| Boiling Point | 467.7±55.0°C (Predicted) |
| Purity | ≥95% |
| Density | 1.92±0.1 g/cm3 (Predicted) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Exact Mass | 287.98800 |
| PSA | 59.59000 |
| Target | HCV |